New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Amphastar Pharmaceuticals, Inc.
AMPH
Shape
US Flag

NASDAQ

2B

Drug Manufacturers - Specialty & Generic

Next Earning date - 13 Nov 2024

2B

Drug Manufacturers - Specialty & Generic

Next Earning date - 13 Nov 2024

49.96USD
Shape0.33 ( 0.66%)
Market Open
favorite-chart

Relative Strenght

20
favorite-chart

Volume Buzz

-90%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

24%

Quote Panel

Shape
Updated October 25, 2024
1W -1.63 % 1M 4.41 % 3M 17.69 % 1Y 11.25 %

Key Metrics

Shape
  • Market Cap

    2.43B


  • Shares Outstanding

    48.68M


  • Share in Float

    36.12M


  • Dividende

    0


  • Earning Date

    13 Nov 2024


  • Price Target

    49.96


  • Average Volume

    352592


  • Beta

    0.826


  • Range

    36.56-65.92


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.amphastar.com


  • Sector

    Healthcare


Fundamentals

Shape

12.47x

P/E Ratio

3.39x

P/S Ratio

3.40x

P/B Ratio

0.8

Debt/Equity

23.4%

Net Margin

$3.1

EPS

How AMPH compares to sector?

P/E Ratio

Relative Strength

Shape

AMPH

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$819M

Shape349%

2025-Revenue

$4.35

Shape457%

2025-EPS

$128M

Shape85%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-17%

0.38
vs 0.46

Q4.22

arrow
arrow

+74%

0.73
vs 0.42

Q1.23

arrow
arrow

+32%

0.62
vs 0.47

Q2.23

arrow
arrow

+67%

0.65
vs 0.39

Q3.23

arrow
arrow

+203%

1.15
vs 0.38

Q4.23

arrow
arrow

+21%

0.88
vs 0.73

Q1.24

arrow
arrow

+68%

1.04
vs 0.62

Q2.24

arrow
arrow

+45%

0.94
vs 0.65

Q3.24

arrow
arrow

-13%

1
vs 1.15

Q4.24

arrow
arrow

+14%

1
vs 0.88

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+7%

120.1M  vs 112.2M

Q4.22

arrow
arrow

+12%

135M  vs 120.9M

Q1.23

arrow
arrow

+16%

140M  vs 120.4M

Q2.23

arrow
arrow

+18%

145.7M  vs 123.5M

Q3.23

arrow
arrow

+50%

180.6M  vs 120.1M

Q4.23

arrow
arrow

+32%

178.1M  vs 135M

Q1.24

arrow
arrow

+23%

171.8M  vs 140M

Q2.24

arrow
arrow

+25%

182.4M  vs 145.7M

Q3.24

arrow
arrow

+8%

194.7M  vs 180.6M

Q4.24

arrow
arrow

+11%

197.9M  vs 178.1M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+3%

0.03
vs 0.03

Q4.22

arrow
arrow

+6%

0.06
vs 0.03

Q1.23

arrow
arrow

+5%

0.05
vs 0.06

Q2.23

arrow
arrow

+4%

0.04
vs 0.05

Q3.23

arrow
arrow

+8%

0.08
vs 0.04

Q4.23

arrow
arrow

+6%

0.06
vs 0.08

Q1.24

arrow
arrow

+6%

0.06
vs 0.06

Q2.24

arrow
arrow

+5%

0.05
vs 0.06

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

205

205
vs 229

-10%

Q4.22

arrow
arrow

214

214
vs 205

4%

Q1.23

arrow
arrow

221

221
vs 214

3%

Q2.23

arrow
arrow

249

249
vs 221

13%

Q3.23

arrow
arrow

257

257
vs 249

3%

Q4.23

arrow
arrow

281

281
vs 257

9%

Q1.24

arrow
arrow

273

273
vs 281

-3%

Q2.24

arrow
arrow

267

267
vs 273

-2%

Earnings Growth

Latest News